Options: Show MedDRA Preferred Terms
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Acute myocardial infarction | x | x | x | x | |||||
| Angina pectoris | x | x | x | x | |||||
| Cardiac failure | x | x | x | x | x | ||||
| Cardiac failure congestive | x | x | x | x | |||||
| Cerebrovascular accident | x | ||||||||
| Diabetes mellitus | x | x | x | x | |||||
| Diabetic nephropathy | x | x | x | x | |||||
| Hyperlipidaemia | x | x | x | x | |||||
| Hypertension | x | x | x | x | x | x | |||
| Hypertensive | x | x | x | x | x | x | x | ||
| Hypotension | x | x | x | x | |||||
| Infarction | x | ||||||||
| Myocardial infarction | x | x | x | x | |||||
| Nephropathy | x | x | x | x | x | x | x | ||
| Renal impairment | x | x | x | x | x | ||||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |